BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32227266)

  • 21. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
    Filippi L; Pelle G; Cianni R; Scopinaro F; Bagni O
    Nucl Med Biol; 2015 Jan; 42(1):59-64. PubMed ID: 25213104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.
    White J; Carolan-Rees G; Dale M; Patrick HE; See TC; Bell JK; Manas DM; Crellin A; Slevin NJ; Sharma RA
    J Vasc Interv Radiol; 2019 Aug; 30(8):1185-1192. PubMed ID: 31255499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study.
    Wu X; Heller M; Lokken RP; Fidelman N; Lam A
    J Vasc Interv Radiol; 2023 May; 34(5):815-823.e1. PubMed ID: 36693521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma.
    Ahmed O; Yu Q; Patel M; Hwang G; Pillai A; Liao CY; Fung J; Baker T
    J Vasc Interv Radiol; 2023 Apr; 34(4):702-709. PubMed ID: 36521794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry.
    Robinson TJ; Du L; Matsuoka L; Sze DY; Kennedy AS; Gandhi RT; Kouri BE; Collins ZS; Kokabi N; Grilli CJ; Wang EA; Lee JS; Brown DB
    J Vasc Interv Radiol; 2023 Apr; 34(4):694-701.e3. PubMed ID: 36509236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of contrast-enhanced CT texture analysis in predicting IDH mutation status of intrahepatic cholangiocarcinoma.
    Zhu Y; Mao Y; Chen J; Qiu Y; Guan Y; Wang Z; He J
    Sci Rep; 2021 Mar; 11(1):6933. PubMed ID: 33767315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.
    Zhao K; Erinjeri JP; Sotirchos VS; Alexander ES; Moussa AM; Marinelli B; Ziv E; Sofocleous CT; Abou-Alfa GK; Jarnagin WR; Karimi A; Yarmohammadi H
    Abdom Radiol (NY); 2023 Jul; 48(7):2434-2442. PubMed ID: 37145313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.
    Reimer P; Virarkar MK; Binnenhei M; Justinger M; Schön MR; Tatsch K
    Cardiovasc Intervent Radiol; 2018 May; 41(5):744-752. PubMed ID: 29344713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography.
    Zhang S; Huang S; He W; Wei J; Huo L; Jia N; Lin J; Tang Z; Yuan Y; Tian J; Shen F; Li J
    Ann Surg Oncol; 2022 Oct; 29(11):6786-6799. PubMed ID: 35789309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab.
    Durot C; Mulé S; Soyer P; Marchal A; Grange F; Hoeffel C
    Eur Radiol; 2019 Jun; 29(6):3183-3191. PubMed ID: 30645669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
    Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
    Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.
    Fiz F; Masci C; Costa G; Sollini M; Chiti A; Ieva F; Torzilli G; Viganò L
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3387-3400. PubMed ID: 35347437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Computed Tomography Features of Intrahepatic Cholangiocarcinoma for Predicting Lymph Node Metastasis and Overall Survival.
    Zhu Y; Mao Y; Chen J; Qiu Y; Wang Z; He J
    J Comput Assist Tomogr; 2019; 43(5):729-735. PubMed ID: 31490892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.
    D'Onofrio M; Vecchiato F; Cantisani V; Barbi E; Passamonti M; Ricci P; Malagò R; Faccioli N; Zamboni G; Pozzi Mucelli R
    Radiol Med; 2008 Feb; 113(1):76-86. PubMed ID: 18338129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy.
    Yang Y; Zou X; Zhou W; Yuan G; Hu D; Kuang D; Shen Y; Xie Q; Zhang Q; Hu X; Li Z
    J Magn Reson Imaging; 2022 Sep; 56(3):739-751. PubMed ID: 35049076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study.
    Mosconi C; Gramenzi A; Ascanio S; Cappelli A; Renzulli M; Pettinato C; Brandi G; Monari F; Cucchetti A; Trevisani F; Golfieri R
    Br J Cancer; 2016 Jul; 115(3):297-302. PubMed ID: 27336601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.
    Park HS; Lee JM; Kim SH; Jeong JY; Kim YJ; Lee KH; Choi SH; Han JK; Choi BI
    AJR Am J Roentgenol; 2006 Aug; 187(2):445-53. PubMed ID: 16861550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Computed tomographic diagnosis of intrahepatic cholangiocarcinoma].
    Hua X; Fu X; Hao Z; Fu Q; Shang H; Chi D
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):449-51. PubMed ID: 24754991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.